General Information of Drug (ID: DMMN36E)

Drug Name
Abacavir Drug Info
Synonyms
Trizivir; Ziagen; Abacavir [INN]; Abacavir (INN); Ziagen (TN); Ziagen (TM)(*Succinate salt*); [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol; {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol; (+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (+/-)-Abacavir; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; ABC
Therapeutic ClassAnti-HIV Agents
Cross-matching ID
PubChem CID
441300
ChEBI ID
CHEMBL1380
CAS Number
CAS 136470-78-5
TTD Drug ID
D0A4IJ
VARIDT Drug ID
DR00588
INTEDE Drug ID
DR0027
ACDINA Drug ID
D00002

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Intestinal immune network for IgA production 2.21 0.00e+0 38/48 (79.17%) CD40;HLA-DPA1;HLA-DQB1;...
Tryptophan metabolism 2.10 0.00e+0 35/42 (83.33%) ALDH2;KYNU;DLD;...
Allograft rejection 2.08 4.40e-3 32/38 (84.21%) CD40;HLA-DPA1;HLA-DQB1;...
Pentose phosphate pathway 2.05 6.60e-3 25/30 (83.33%) PFKL;DERA;G6PD;...
Asthma 2.05 5.28e-3 25/31 (80.65%) CD40;HLA-DPA1;HLA-DQB1;...
Autoimmune thyroid disease 2.04 4.40e-3 46/53 (86.79%) CD40;HLA-DPA1;HLA-DQB1;...
Graft-versus-host disease 1.94 7.55e-3 32/42 (76.19%) HLA-DPA1;HLA-DQB1;HLA-DMB;...
Valine, leucine and isoleucine degradation 1.89 1.16e-2 42/48 (87.5%) ALDH2;HMGCS1;DLD;...
Systemic lupus erythematosus 1.87 1.03e-2 45/135 (33.33%) CD40;HLA-DPA1;HLA-DQB1;...
Citrate cycle (TCA cycle) 1.82 1.98e-2 30/30 (100%) DLD;IDH2;CS;...
Carbohydrate digestion and absorption 1.81 2.04e-2 37/47 (78.72%) SLC37A4;PLCB1;FXYD2;...
Salivary secretion 1.81 1.87e-2 76/93 (81.72%) PLCB1;FXYD2;PRKACB;...
beta-Alanine metabolism 1.74 3.05e-2 25/30 (83.33%) ALDH2;ALDH3A2;ALDH3A1;...
Thyroid hormone signaling pathway 1.74 3.30e-2 112/121 (92.56%) SRC;PFKL;BMP4;...
Type I diabetes mellitus 1.73 3.17e-2 38/43 (88.37%) HLA-DPA1;HLA-DQB1;HLA-DMB;...
Glycolysis / Gluconeogenesis 1.73 3.14e-2 56/67 (83.58%) ALDH2;DLD;PFKL;...
Th1 and Th2 cell differentiation 1.72 3.11e-2 80/92 (86.96%) HLA-DPA1;HLA-DQB1;HLA-DMB;...
Histidine metabolism 1.69 4.18e-2 16/22 (72.73%) ALDH2;ALDH3A2;ALDH3A1;...
Cortisol synthesis and secretion 1.68 4.31e-2 58/65 (89.23%) NR4A1;PLCB1;PRKACB;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.01uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.04uM - 10uM 24H